Published in Clin Radiol on May 20, 2011
The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 17.41
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med (2013) 8.89
Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science (1997) 8.43
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89
Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell (1996) 7.81
Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science (1999) 5.22
The immunological synapse. Annu Rev Immunol (2001) 4.45
A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell (1998) 4.21
Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell (1994) 3.71
Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest (2001) 3.22
Signal transduction: hanging on a scaffold. Curr Opin Cell Biol (2000) 2.96
Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1. J Immunol (1992) 2.79
Palmitylation of an amino-terminal cysteine motif of protein tyrosine kinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins. Mol Cell Biol (1993) 2.29
The immunological synapse and CD28-CD80 interactions. Nat Immunol (2001) 2.23
Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. Science (1998) 2.13
14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol Cell Biol (1998) 2.07
Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition. Semin Immunol (2000) 2.06
CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol (2001) 1.97
The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia (2004) 1.92
p59fyn tyrosine kinase associates with multiple T-cell receptor subunits through its unique amino-terminal domain. Mol Cell Biol (1992) 1.87
Thrombelastography. Blood Coagul Fibrinolysis (2001) 1.83
Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med (1990) 1.77
P62 association with RNA is regulated by tyrosine phosphorylation. J Biol Chem (1995) 1.59
Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1. Mol Cell Biol (1995) 1.58
Survival after induction chemotherapy and surgical resection for high-grade soft tissue sarcoma. Is radiation necessary? Ann Surg Oncol (2001) 1.53
The 14-3-3 proteins positively regulate rapamycin-sensitive signaling. Curr Biol (1998) 1.53
The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J Biol Chem (1995) 1.51
Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clin Radiol (2011) 1.50
Distinct p53/56lyn and p59fyn domains associate with nonphosphorylated and phosphorylated Ig-alpha. Proc Natl Acad Sci U S A (1994) 1.49
Costimulation: building an immunological synapse. Science (1999) 1.48
CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere. Am J Physiol Renal Physiol (2000) 1.48
Thromboembolism and the combined oral contraceptive pill. Lancet (1995) 1.47
Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J Immunol (2001) 1.47
Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif. Mol Cell Biol (1994) 1.45
Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J Exp Med (1999) 1.44
DdeI polymorphism in intron 5 of the ATIII gene. Nucleic Acids Res (1990) 1.44
Regulation of antigen receptor signal transduction by protein tyrosine kinases. Curr Opin Immunol (1996) 1.38
Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency. Br J Haematol (2006) 1.34
Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol Cell Biol (1996) 1.32
Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase. Immunity (1995) 1.28
Binding of ZAP-70 to phosphorylated T-cell receptor zeta and eta enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins. Mol Cell Biol (1995) 1.27
Analysis of the interaction of ZAP-70 and syk protein-tyrosine kinases with the T-cell antigen receptor by plasmon resonance. Proc Natl Acad Sci U S A (1995) 1.26
Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Mol Cell Biol (1995) 1.26
Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines. J Immunol (1995) 1.20
Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (1997) 1.15
Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp) J Clin Invest (1994) 1.14
Prevalence of antithrombin deficiency in the healthy population. Br J Haematol (1994) 1.13
Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease. Eur Respir J (1998) 1.07
Re: Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 1.06
CD28 and the tyrosine kinase lck stimulate mitogen-activated protein kinase activity in T cells via inhibition of the small G protein Rap1. Mol Cell Biol (2000) 1.06
Imaging patients with myeloma. Clin Radiol (2008) 1.06
Identification of an interferon-gamma receptor alpha chain sequence required for JAK-1 binding. J Biol Chem (1996) 1.05
PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology (1992) 1.05
A comparison of randomized concurrent control groups with matched historical control groups: are historical controls valid? J Clin Oncol (1986) 1.03
Aryl hydrocarbon (Ah) receptor DNA-binding activity. Sequence specificity and Zn2+ requirement. J Biol Chem (1990) 1.03
Environmental control of immunological synapse formation and duration. Trends Immunol (2001) 1.01
Coordinate regulation of T cell activation by CD2 and CD28. J Immunol (2000) 1.00
HIV-1 Nef protein downregulation of CD4 surface expression: relevance of the lck binding domain of CD4. Virology (1995) 0.99
Familial and racial determinants of tumour suppressor genes promoter hypermethylation in breast tissues from healthy women. J Cell Mol Med (2009) 0.98
Multiple features of the p59fyn src homology 4 domain define a motif for immune-receptor tyrosine-based activation motif (ITAM) binding and for plasma membrane localization. J Cell Biol (1996) 0.94
Multiple DNA-binding factors interact with overlapping specificities at the aryl hydrocarbon response element of the cytochrome P450IA1 gene. Mol Cell Biol (1990) 0.92
Eosinophilia associated with adult T-cell leukemia/lymphoma. Cancer (1988) 0.89
Mechanism of action of interferon-tau in the uterus during early pregnancy. J Reprod Fertil Suppl (1999) 0.87
Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature. Pituitary (2012) 0.87
Evidence from sequence-tagged-site markers of a recent progenitor-derivative species pair in conifers. Proc Natl Acad Sci U S A (2000) 0.87
A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies. Haemophilia (2009) 0.87
Virtual unenhanced second generation dual-source CT of the liver: is it time to discard the conventional unenhanced phase? Eur J Radiol (2011) 0.87
Response assessment in lymphoma. Clin Radiol (2007) 0.86
Lesions of the patellar ligament. J Bone Joint Surg Br (1990) 0.86
A framework for genetic service provision for haemophilia and other inherited bleeding disorders. Haemophilia (2005) 0.86
Uptake of BRL 41897A, a C(7) alpha-formamido substituted cephalosporin, via the ferri-pyochelin transport system of Pseudomonas aeruginosa. J Antimicrob Chemother (1994) 0.85
An internalized amino-terminal signal sequence retains full activity in vivo but not in vitro. J Biol Chem (1987) 0.85
Right heart obstruction due to intracavitary prolymphocytic leukemia. Am J Med (1986) 0.84
Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck. Cancer (1982) 0.84
Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation. Blood Coagul Fibrinolysis (1996) 0.84
Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin binding. FEBS Lett (1990) 0.84
Some physical considerations in whole skin electron beam therapy. Med Phys (1983) 0.83
CD28 and T cell co-stimulation. Rev Immunogenet (2000) 0.83
The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic disease. Br J Haematol (1991) 0.82
Small cell carcinocythemia. Arch Pathol Lab Med (1999) 0.82
Investigation of copper-PTSM as a PET tracer for tumor blood flow. Int J Rad Appl Instrum B (1991) 0.82
Antithrombin Dublin (-3 Val----Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site. FEBS Lett (1990) 0.82
Pseudoaneurysm as a complication of arthroscopy: a case report. J Oral Maxillofac Surg (1991) 0.82
Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency. Thromb Haemost (2000) 0.81
Statistical analysis of beta 2-microglobulin levels in sera of lung and GI tract cancer patients. Vox Sang (1980) 0.81
The role of individual Fc gamma receptors in aggregated IgG-stimulated protein tyrosine phosphorylation in the human neutrophil. Biochem Biophys Res Commun (1994) 0.81
Phenotypic characterization and analysis of allogeneic T cell responses in ZAP-70 dominant negative transgenic mice. Clin Exp Immunol (1997) 0.81
Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency. Haemophilia (2008) 0.80
Penicillin-induced leukopenia. N Engl J Med (1982) 0.80
Antithrombin III: a database of mutations. Thromb Haemost (1991) 0.80
Structural interpretation of 42 mutations causing factor XI deficiency using homology modeling. J Thromb Haemost (2005) 0.80
Clinical experience with the use of clotting factor concentrates in oral anticoagulation reversal. Clin Lab Haematol (1998) 0.80
Education and imaging. Hepatobiliary and pancreatic: peliosis hepatis. J Gastroenterol Hepatol (2011) 0.80
Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion. Eye (Lond) (1995) 0.79
Genetic testing in bleeding disorders. Haemophilia (2014) 0.79
Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue. Pathologica (2012) 0.79
Imaging acute pancreatitis. Br J Radiol (2010) 0.79
Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy. Cancer Treat Rep (1983) 0.78